Statins and Reduced Risk of Liver Cancer: Evidence for Confounding.

about

Peretinoin as an adjuvant therapy for hepatocellular carcinoma.

P2860

Q38959682-E6D74C79-0045-4D5C-B7D7-14E6814FF2B3

P2860

Statins and Reduced Risk of Liver Cancer: Evidence for Confounding.

Item

http://www.wikidata.org/entity/Q39629218

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Statins and Reduced Risk of Liver Cancer: Evidence for Confounding.

@en

Statins and Reduced Risk of Liver Cancer: Evidence for Confounding.

@nl

type

Item

label

Statins and Reduced Risk of Liver Cancer: Evidence for Confounding.

@en

Statins and Reduced Risk of Liver Cancer: Evidence for Confounding.

@nl

prefLabel

Statins and Reduced Risk of Liver Cancer: Evidence for Confounding.

@en

Statins and Reduced Risk of Liver Cancer: Evidence for Confounding.

@nl

P1476

Statins and Reduced Risk of Liver Cancer: Evidence for Confounding

@en

P2093

Bruce Fireman

http://www.w3.org/2001/XMLSchema#string

Gary D Friedman

http://www.w3.org/2001/XMLSchema#string

Ninah Achacoso

http://www.w3.org/2001/XMLSchema#string

P2860

Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy

American Diabetes Association indications for statins in diabetes: is there evidence?

Increasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial results

Statin use and risk of liver cancer: an update meta-analysis.

Statin use and risk of primary liver cancer in the Clinical Practice Research Datalink.

Final conclusions and recommendations of the National Lipid Association Statin Safety Assessment Task Force.

Liver cirrhosis and diabetes: risk factors, pathophysiology, clinical implications and management

Statins are associated with a reduced risk of hepatocellular cancer: a systematic review and meta-analysis.

Metabolic risk factors and primary liver cancer in a prospective study of 578,700 adults.

P31

scholarly article

P356

10.1093/JNCI/DJW109

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

108

http://www.w3.org/2001/XMLSchema#string

P50

Laurel A Habel

P577

2016-07-05T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27381455

http://www.w3.org/2001/XMLSchema#string

P932

6437715

http://www.w3.org/2001/XMLSchema#string

Statins and Reduced Risk of Liver Cancer: Evidence for Confounding.

about

P2860

P2860

Statins and Reduced Risk of Liver Cancer: Evidence for Confounding.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P31

P356

P407

P433

P478

P50

P577

P698

P932